Nema internetske veze — prikazuje se spremljena verzija stranice.

Evotec SE

DEEUR
← Na filtar dionica

Evotec SE (XETRA:EVT) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 3. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O tvrtki

Web-stranica
evotec.com
Odnosi s investitorima
evotec.com/ir-news/investor-relations
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
HAMBURG, Germany
Glavni direktor
Dr. Christian Wojczewski Ph.D.
Zaposlenici
4 461
Na burzi od
12.11.1999 (XETRA:EVT)
Dionice u optjecaju
177.69 mil.
Slobodno prenosive dionice
135.49 mil.
Tržišna kapitalizacija
521.36 mil. EUR
Insajderi
9.97%
Institucionalni ulagači
60.05%
Djelatnost (SIC)
Pharmaceutical Preparations
Opis

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Burze i oznake

BurzaOznakaValutaCijenaVrsta
XETRA XetraEVT glavnaEUR3.028 -2.32%obične dionice
LSE London Stock Exchange0IRF IOBEUR25.98 +0.00%obične dionice
US USA StocksEVOTF OTCUSD3.325 -50.30%obične dionice

Cijena za 3 mjeseca

XETRA:EVT · EUR
dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Isplate dividendi nisu pronađene (provjereno 08.10.2026). Tvrtka vjerojatno ne isplaćuje dividende.

Vijesti ovog tjedna

Nema vijesti u zadnjem tjednu. Najnovije vijesti: 29.09.2026.

oglas

Najveći imatelji

ImateljUdioDioniceDatum izvješća
First TRT Exch-Trd Fd.-F…1.46%2.6 mil.2026-06-30
VANGUARD STAR FUNDS-Vang…1.31%2.32 mil.2026-07-31
Brown Capital Mgmt Mutua…1.12%2 mil.2026-06-30
VANGUARD TAX-MANAGED FUN…0.87%1.55 mil.2026-06-30
iShares Trust-iShares Co…0.62%1.1 mil.2026-08-31
VANGUARD Intl Eqy. INDEX…0.37%660 9782026-07-31
DCF Advisers, LLC0.33%1.08 mil.2026-06-30
JNL Series Trust-JNL Mul…0.3%530 5352026-06-30
DFA INVESTMENT DIMENSION…0.27%477 8302026-07-31
iShares Trust-iShares MS…0.26%469 7002026-08-31
DFA INVESTMENT DIMENSION…0.23%414 2812026-07-31
WCM Investment Managemen…0.2%671 8842026-06-30
ABC Arbitrage SA0.11%371 9362026-06-30
Optiver Holding B.v.0.1%322 1532026-06-30
Morgan Stanley0.06%205 7632026-06-30
LPL Financial LLC0.05%166 0452026-06-30
Envestnet Asset Manageme…0.04%139 5962026-06-30
Old Mission Capital, LLC0.01%38 0322026-06-30
Pathstone Holdings, LLC0.01%35 7792026-06-30
Fore Capital, LLC0.01%31 3552026-06-30
Fidelity Concord Street…0%11 2722026-07-31